Global Next Generation Cancer Diagnostics Market By Product Type (Liquid Biopsy, Genetic Testing, Next Generation Sequencing, Immunoassays, and Radiomics), By Application (Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, and Leukemia), By End-user (Hospitals, Research Institutions, Laboratories, and Diagnostic Centers), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
Report Overview Global Next generation cancer diagnostics Market size is expected to be worth around US$ 39.1 billion by 2034 from US$ 16.2 billion in 2024, growing at a CAGR of 9.2%...
